Arginine-NO metabolites are associated with morbidity in single ventricle infants undergoing stage 2 palliation

Benjamin S. Frank,Sierra Niemiec,Ludmila Khailova,Christopher A. Mancuso,Tanner Lehmann,Max B. Mitchell,Gareth J. Morgan,Mark Twite,Michael V. DiMaria,Jelena Klawitter,Jesse A. Davidson
DOI: https://doi.org/10.1038/s41390-024-03162-y
IF: 3.953
2024-04-03
Pediatric Research
Abstract:Infants with single ventricle heart disease (SVHD) suffer morbidity from insufficient pulmonary blood flow, which may be related to impaired arginine metabolism. No prior study has reported quantitative mapping of arginine metabolites to evaluate the relationship between circulating metabolite levels and outcomes.
pediatrics
What problem does this paper attempt to address?